Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.40 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25944318 | 0.87 | SNCA (0.50) | MEN1KMT2AMAPTTERTSNCA | |
| SCHEMBL19050353 | 0.74 | RAD1 (0.40) | MEN1KMT2AMAPTSNCA | |
| SCHEMBL25208467 | 0.73 | F3 (0.77) | F3MEN1KMT2AMAPTCXCL12 | |
| SCHEMBL25198993 | 0.73 | F3 (0.77) | F3MEN1KMT2AMAPTCXCL12 | |
| SCHEMBL29625135 | 0.72 | SNCA (0.62) | MAPTTERTSNCACXCL12 | |
| SCHEMBL25339938 | 0.72 | SNCA (0.62) | MAPTTERTSNCACXCL12 | |
| SCHEMBL30383878 | 0.66 | CYP3A4 (0.58) | KMT2AMAPTTERTSNCACXCL12 | |
| SCHEMBL14342093 | 0.66 | CYP3A4 (0.58) | KMT2AMAPTTERTSNCACXCL12 | |
| SCHEMBL16303864 | 0.66 | EGFR (0.46) | PTGS2MEN1KMT2AMAPTTERT | |
| SCHEMBL14397151 | 0.65 | LMNA (0.57) | MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4223740-A1 | TYROSINASE-INHIBITING MOLECULES AND DERMOPHARMACEUTICAL COMPOSITION THAT INCLUDES THEM | Mesoestetic Pharma Group, S.L. (ES) | 2023-08-09 | — | — | EP | disclosed |